{"nct_id":"NCT04551053","title":"To Evaluate Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis Who Have Suboptimal Response to Ruxolitinib (LIMBER-304)","status":"TERMINATED","status_verified_date":"2025-09","start_date":"2021-05-26","start_date_type":"ACTUAL","primary_completion_date":"2023-08-16","primary_completion_date_type":"ACTUAL","completion_date":"2024-08-21","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["INCY"]}